The Greenrose Holding Company Inc. (OTCPK: GNRS.Q)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
The Greenrose Holding Company Inc. (OTCPK: GNRS.Q) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $18.00 and employs 91 people.
trading between 0.00 and 0.20.
Tweenvest scores The Greenrose Holding Company Inc. across four factors: quality 28/100, value 69/100. Its strongest factor is value.
GNRS.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $18.00
- Revenue (TTM)
- $28.40M
- P/E
- —
- EPS
- -1.09
- Dividend yield
- —
- Beta (5Y)
- 452.51
- 52-week high
- $0.20
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 17.68M
- Employees
- 91
- Next earnings
- —
About The Greenrose Holding Company Inc.
Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.
- ISIN
- US3953921034
- Founded
- 2014
- Listed since
- May 21, 2020
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.